Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10695325
Compounds and methods for treating an epileptic disorder
granted -
US 10688285
Spinal subpial gene delivery system
granted -
US 10688080
Compositions, methods of use, and methods of treatment
granted -
US 10688181
Cancer treatment combinations
granted -
US 10688453
System and method for droplet formation and manipulation using ferrofluids
granted -
US 10689595
Synthesis and use of omega-hydroxylated polyunsaturated fatty acids
granted -
US 10688160
Enzymes and methods for cleaving N-glycans from glycoproteins
granted -
US 10682368
Methods of treating feline coronavirus infections
granted -
US 10682425
Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
granted -
US 10683347
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
granted -
US 10676759
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10676792
Prognostic and diagnostic methods for colorectal cancer
granted -
US 10675273
Benzothiazole amphiphiles
granted -
US 10675267
Methods for detection and eradication of myeloid leukemia stem cells
granted -
US 10675307
Compositions comprising perivascular stem cells and nell-1 protein
granted -
US 10676534
Vaults engineered for hydrophobic drug delivery
granted -
US 10668118
Microbial consortium and uses thereof
granted -
US 10668161
Therapeutic hyperbranched polyglycerol encapsulated biomolecules
granted -
US 10669560
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10668024
Mesoporous silica nanoparticles for biomedical applications
granted -
US 10667994
Bioactive dental restorative material with remineralization properties
granted -
US 10668015
Unit aerosol doses for anticoagulation
granted -
US 10668049
Methods of treating cognitive decline with transforming growth factor beta inhibitors
granted -
US 10668129
Synergistic combination of neuronal viability factors and uses thereof
granted